Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization

The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization. While monitoring for tumor response after transarterial chemoembolization is crucial, current imaging strategies are suboptimal....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiol Case Rep
Main Authors: Gummadi, Sriharsha, Stanczak, Maria, Lyshchik, Andrej, Forsberg, Flemming, Shaw, Colette M., Eisenbrey, John R.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2018
Assuntos:
Sonography
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930180/
https://ncbi.nlm.nih.gov/pubmed/29721125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2018.04.001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares